相关实验视频
Updated: Jun 11, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
在Rezum治疗3个月后,在下泌尿道症状中实现最小的临床重要差异的预测因素
Mustufa Babar1,2, Max Abramson1, Kevin Labagnara1
1Albert Einstein College of Medicine, New York, United States of America.
在大多数患者中,Rezūm治疗有效地改善了下泌尿道症状 (LUTS). 严重的LUTS和更大的前列腺体积 (≥60cc) 预测了 Rezūm 治疗后的成功结果和早期缓解.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 最少侵入性手术的方法
- 患者的治疗结果.
背景情况:
- 预测手术成功对于患者的结果和手术前咨询至关重要.
- 确定影响下尿道症状 (LUTS) 治疗疗效的因素至关重要.
研究的目的:
- 为了确定在Rezūm治疗后三个月在LUTS中实现最小临床重要差异 (MCID) 的预测因素.
- 改进患者选择和手术前咨询,以改善患者选择和手术前咨询.
主要方法:
- 对接受Rezūm治疗中度至重度LUTS的患者进行了回顾性研究.
- 患者分为MCID (≥25%的IPSS改善) 和非MCID队列3个月.
- 多变量逻辑回归分析以确定MCID的预测因素.
主要成果:
- 77%的患者在Rezūm.后3个月内实现了MCID.
- 较高的基线国际前列腺症状得分 (IPSS) 和严重的LUTS预测了MCID.
- 较大的前列腺基线体积 (≥60 cc) 也是实现MCID的显著预测因素.
结论:
- 雷祖显示出高效率,超过四分之三的患者实现了显著的症状改善.
- 患有严重LUTS和前列腺体积≥60cc的患者是Rezūm.早期LUTS缓解的最佳候选人.
更多相关视频
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
02:41Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
相关概念视频
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi V: Nursing Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...